Healthcare provider profile · identity verified

Ali Sangi, MD

Family Practice · SPRINGFIELD, OR · NPI 1083268494

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	405	125
Amlodipine Besylate	Amlodipine Besylate	290	85
Lisinopril	Lisinopril	225	70
Levothyroxine Sodium	Levothyroxine Sodium	221	59
Losartan Potassium	Losartan Potassium	148	44
Eliquis	Apixaban	146	34
Gabapentin	Gabapentin	139	42
Tamsulosin Hcl	Tamsulosin Hcl	125	34
Metoprolol Succinate	Metoprolol Succinate	109	33
Carvedilol	Carvedilol	104	34
Omeprazole	Omeprazole	97	34
Rosuvastatin Calcium	Rosuvastatin Calcium	93	31
Metformin Hcl Er	Metformin Hcl	90	24
Pantoprazole Sodium	Pantoprazole Sodium	90	30
Trazodone Hcl	Trazodone Hcl	90	29
Hydrochlorothiazide	Hydrochlorothiazide	76	26
Ozempic	Semaglutide	73	17
Metformin Hcl	Metformin Hcl	72	23
Pravastatin Sodium	Pravastatin Sodium	71	22
Oxycodone Hcl	Oxycodone Hcl	70	16
Jardiance	Empagliflozin	60	19
Furosemide	Furosemide	56	23
Albuterol Sulfate Hfa	Albuterol Sulfate	52	29
Famotidine	Famotidine	52	12
Warfarin Sodium	Warfarin Sodium	51	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	15
Escitalopram Oxalate	Escitalopram Oxalate	49	14
Fluticasone Propionate	Fluticasone Propionate	49	20
Lovastatin	Lovastatin	49	suppressed
Alendronate Sodium	Alendronate Sodium	42	18
Bupropion Xl	Bupropion Hcl	42	suppressed
Glipizide	Glipizide	42	suppressed
Tramadol Hcl	Tramadol Hcl	40	15
Metoprolol Tartrate	Metoprolol Tartrate	39	16
Simvastatin	Simvastatin	39	12
Potassium Chloride	Potassium Chloride	38	11
Torsemide	Torsemide	38	suppressed
Buspirone Hcl	Buspirone Hcl	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	20
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Sertraline Hcl	Sertraline Hcl	35	14
Diclofenac Sodium	Diclofenac Sodium	34	17
Ezetimibe	Ezetimibe	34	suppressed
Mounjaro	Tirzepatide	34	suppressed
Donepezil Hcl	Donepezil Hcl	33	suppressed
Allopurinol	Allopurinol	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	12
Meloxicam	Meloxicam	32	11
Mirtazapine	Mirtazapine	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Prednisone	Prednisone	30	19
Spironolactone	Spironolactone	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	12
Lorazepam	Lorazepam	27	11
Montelukast Sodium	Montelukast Sodium	25	suppressed
Finasteride	Finasteride	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Baclofen	Baclofen	23	suppressed
Celecoxib	Celecoxib	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Ondansetron Odt	Ondansetron	23	14
Glimepiride	Glimepiride	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Nystatin	Nystatin	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Pregabalin	Pregabalin	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Cephalexin	Cephalexin	16	15
Clonidine Hcl	Clonidine Hcl	16	suppressed
Diazepam	Diazepam	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Valsartan	Valsartan	16	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Atenolol	Atenolol	14	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Digoxin	Digoxin	14	suppressed
Estradiol	Estradiol	14	suppressed
Olanzapine	Olanzapine	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Nyamyc	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error